🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study of Two Dosing Schedules of Adalimumab in Subjects with Moderate to Se...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00645905
Treatments Being Tested
The objective of this multicenter, randomized, double-blind study was to ev...
Status
Completed
Location
Multiple Locations
Start Date
2013-04-16
Trial ID
NCT01808118
Treatments Being Tested
This is a multicenter, Phase 3 randomized, placebo-controlled study designe...
Status
Completed
Location
Site Ref # / Investigator 45524
Start Date
2002-09
Trial ID
NCT00048542
The primary objective of this study was to evaluate the tolerability and sa...
Status
Terminated
Location
Research Site
Start Date
2006-05
Trial ID
NCT00298272
Treatments Being Tested
Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to...
Status
Completed
Location
Multiple Locations
Start Date
2003-03
Trial ID
NCT00646191
Treatments Being Tested
The purpose of this study is to evaluate the long term efficacy and safety ...
Status
Completed
Location
Multiple Locations
Start Date
2010-11-23
Trial ID
NCT01148225
Treatments Being Tested
This was a multicenter, open-label study to evaluate the human monoclonal a...
Status
Completed
Location
Multiple Locations
Start Date
2008-05-01
Trial ID
NCT00686374
Treatments Being Tested
This study compared the safety and efficacy of combination therapy with ada...
Status
Completed
Location
Site Reference ID/Investigator# 4560
Start Date
2006-12
Trial ID
NCT00420927
Treatments Being Tested
The purpose of the study was to assess the safety, immunogenicity, and clin...
Status
Completed
Location
Site Ref # / Investigator 424
Start Date
2000-02
Trial ID
NCT00195702
Treatments Being Tested
To evaluate the potential of adalimumab to inhibit radiographic progression...
Status
Completed
Location
Site Reference ID/Investigator# 46861
Start Date
2009-03
Trial ID
NCT00870467
Treatments Being Tested